Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...
FORT LAUDERDALE, FL / ACCESS Newswire / March 10, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company ...
Holdings announced that its supplemental new drug application, sNDA, of Gvoke VialDx has received U.S Food and Drug ...
Sunshine Biopharma (SBFM) announced that its wholly owned Canadian subsidiary, Nora Pharma, has acquired the rights to two gastrointestinal ...
This and the forthcoming drug are part of Sunshine Biopharma’s strategy to penetrate the chronic idiopathic constipation market, which is part of the larger gastrointestinal market with annual ...
Both Prucalopride and the second drug Sunshine Biopharma is planning to launch by year end are in the chronic idiopathic constipation submarket of the total gastrointestinal market currently ...
This and the forthcoming drug are part of Sunshine Biopharma’s strategy to penetrate the chronic idiopathic constipation market, which is part of the larger gastrointestinal market with annual sales ...